UroGen Pharma Ltd.

URGN ·Healthcare, Drug Manufacturers - General, Israel
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Oct 9, 2026 FORM 4
144 Oct 9, 2026
4 Sep 9, 2026 FORM 4
4 Sep 9, 2026 FORM 4
144 Sep 9, 2026
144 Sep 9, 2026
4 Aug 28, 2026 FORM 4
4 Aug 24, 2026 FORM 4
144 Aug 20, 2026
8-K Aug 20, 2026 FORM 8-K
SCHEDULE 13G/A Aug 12, 2026
10-Q Aug 5, 2026 FORM 10-Q
8-K Aug 5, 2026 FORM 8-K
4 Jul 10, 2026 FORM 4
144 Jul 9, 2026
4 Jun 24, 2026 FORM 4
4 Jun 24, 2026 FORM 4
4 Jun 24, 2026 FORM 4
4 Jun 24, 2026 FORM 4
4 Jun 24, 2026 FORM 4
4 Jun 24, 2026 FORM 4
4 Jun 24, 2026 FORM 4
8-K Jun 23, 2026 FORM 8-K
144 Jun 22, 2026
4 Jun 9, 2026 FORM 4
← Newer Page 1 of 24 · 579 filings Older →